Cosmo Pharmaceuticals Statistics

Total Valuation

SWX:COPN has a market cap or net worth of CHF 964.11 million. The enterprise value is 838.39 million.

Market Cap	964.11M
Enterprise Value	838.39M

Important Dates

The next estimated earnings date is Wednesday, July 23, 2025.

Earnings Date	Jul 23, 2025
Ex-Dividend Date	Jun 4, 2025

Share Statistics

SWX:COPN has 16.02 million shares outstanding. The number of shares has increased by 1.94% in one year.

Current Share Class	16.02M
Shares Outstanding	16.02M
Shares Change (YoY)	+1.94%
Shares Change (QoQ)	+3.31%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	16.99%
Float	8.52M

Valuation Ratios

The trailing PE ratio is 7.91.

PE Ratio	7.91
Forward PE	n/a
PS Ratio	3.85
PB Ratio	2.03
P/TBV Ratio	3.29
P/FCF Ratio	6.51
P/OCF Ratio	6.33
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.54, with an EV/FCF ratio of 5.66.

EV / Earnings	6.71
EV / Sales	3.35
EV / EBITDA	5.54
EV / EBIT	6.00
EV / FCF	5.66

Financial Position

The company has a current ratio of 4.19, with a Debt / Equity ratio of 0.00.

Current Ratio	4.19
Quick Ratio	3.39
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.01
Interest Coverage	2,809.10

Financial Efficiency

Return on equity (ROE) is 29.31% and return on invested capital (ROIC) is 20.39%.

Return on Equity (ROE)	29.31%
Return on Assets (ROA)	15.87%
Return on Invested Capital (ROIC)	20.39%
Return on Capital Employed (ROCE)	24.88%
Revenue Per Employee	777,307
Profits Per Employee	388,193
Employee Count	322
Asset Turnover	0.45
Inventory Turnover	3.27

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.92% in the last 52 weeks. The beta is 1.30, so SWX:COPN's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	-15.92%
50-Day Moving Average	51.72
200-Day Moving Average	63.53
Relative Strength Index (RSI)	69.26
Average Volume (20 Days)	23,744

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SWX:COPN had revenue of CHF 250.29 million and earned 125.00 million in profits. Earnings per share was 7.61.

Revenue	250.29M
Gross Profit	207.74M
Operating Income	139.68M
Pretax Income	143.88M
Net Income	125.00M
EBITDA	150.55M
EBIT	139.68M
Earnings Per Share (EPS)	7.61

Full Income Statement

Balance Sheet

The company has 134.12 million in cash and 2.06 million in debt, giving a net cash position of 132.06 million or 8.25 per share.

Cash & Cash Equivalents	134.12M
Total Debt	2.06M
Net Cash	132.06M
Net Cash Per Share	8.25
Equity (Book Value)	473.86M
Book Value Per Share	29.19
Working Capital	144.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 152.37 million and capital expenditures -4.27 million, giving a free cash flow of 148.10 million.

Operating Cash Flow	152.37M
Capital Expenditures	-4.27M
Free Cash Flow	148.10M
FCF Per Share	9.25

Full Cash Flow Statement

Margins

Gross margin is 83.00%, with operating and profit margins of 55.81% and 49.94%.

Gross Margin	83.00%
Operating Margin	55.81%
Pretax Margin	57.49%
Profit Margin	49.94%
EBITDA Margin	60.15%
EBIT Margin	55.81%
FCF Margin	59.17%

Dividends & Yields

This stock pays an annual dividend of 1.93, which amounts to a dividend yield of 3.26%.

Dividend Per Share	1.93
Dividend Yield	3.26%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	24.09%
Buyback Yield	-1.94%
Shareholder Yield	1.32%
Earnings Yield	12.97%
FCF Yield	15.36%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SWX:COPN has an Altman Z-Score of 7.21.

Altman Z-Score	7.21
Piotroski F-Score	n/a